Page last updated: 2024-11-02

pd 98059 and Altitude Hypoxia

pd 98059 has been researched along with Altitude Hypoxia in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Altitude Hypoxia: Low ambient oxygen tension associated with ALTITUDE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, YF2
Ji, LH2
Feng, TT2
Liu, F2
Cui, S2
Su, J2
Ren, R1
Li, JP1
Luo, W1

Other Studies

2 other studies available for pd 98059 and Altitude Hypoxia

ArticleYear
[Effect of ERK1/2 Signaling Pathway Inhibitor PD98059 on the Expression of Ras, BRaf, MEK, ERK1/2 in Marrow Nucleated Red Blood Cells of CMS Patients].
    Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:5

    Topics: Altitude Sickness; Bone Marrow; Flavonoids; Humans; Mitogen-Activated Protein Kinase 3; Proto-Oncoge

2017
[Effect of PD98059 on Proliferation and Apoptosis of CD71(+),CD235a(+) Nucleated Erythrocytes in the Patients with High Altitude Polycythemia].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:4

    Topics: Altitude Sickness; Apoptosis; Bone Marrow; Bone Marrow Cells; Cell Proliferation; Erythroblasts; Ery

2016